Advertisement
Screener

WARNER CHILCOTT PLC Forms 3, 4 and 5: Stock Options, 2009

WARNER CHILCOTT PLC Forms 3, 4 and 5: Stock Options

Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 13 rows in 2009. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.

  • 2009-10-20: Reporting owner Fawzi Mahdi B; Form 4; Security Option to purchase ordinary shares par value $0.01 per share; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
  • 2009-08-05: Reporting owner Burgstahler David F; Form 4; Security Option to purchase Class A common shares, par value $0.01; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
  • 2009-08-05: Reporting owner BLOEM JAMES H; Form 4; Security Option to purchase Class A common shares, par value $0.01; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
  • 2009-08-05: Reporting owner O'Sullivan Patrick J; Form 4; Security Option to purchase Class A common shares, par value $0.01; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
Transaction dateReporting ownerFormSecurityTransactionSharesPricePrice that dayFiling
2009-10-20Fawzi Mahdi B
Officer (President, Research & Develop.)
4Option to purchase ordinary shares par value $0.01 per share
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+65,830
65,830 owned after
$22.98
exercise price
2009-10-22
2009-08-05Burgstahler David F
Director
4Option to purchase Class A common shares, par value $0.01
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+15,300
15,300 owned after
$16.01
exercise price
2009-08-07
2009-08-05BLOEM JAMES H
Director
4Option to purchase Class A common shares, par value $0.01
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+15,300
15,300 owned after
$16.01
exercise price
2009-08-07
2009-08-05O'Sullivan Patrick J
Director
4Option to purchase Class A common shares, par value $0.01
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+15,300
15,300 owned after
$16.01
exercise price
2009-08-07
2009-08-05KING JOHN A
Director
4Option to purchase Class A common shares, par value $0.01
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+15,300
15,300 owned after
$16.01
exercise price
2009-08-07
2009-01-20Hara Izumi
Officer (Sr. VP, Gen. Counsel & Sec.)
4Options to purchase Class A common shares, par value $0.01
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+32,710
64,500 owned after
$13.29
exercise price
2009-01-22
2009-01-20Ellman Herman
Officer (Senior V.P., Clinical Devel.)
4Options to purchase Class A common shares, par value $0.01
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+32,710
60,770 owned after
$13.29
exercise price
2009-01-22
2009-01-20Cross Leland H
Officer (Senior V.P., Tech. Operations)
4Options to purchase Class A common shares, par value $0.01
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+29,590
57,650 owned after
$13.29
exercise price
2009-01-22
2009-01-20Howard Alvin D
Officer (Sr. V.P., Regulatory Affairs)
4Options to purchase Class A common shares, par value $0.01
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+34,260
66,780 owned after
$13.29
exercise price
2009-01-22
2009-01-20Boissonneault Roger M
Director, Officer (CEO & President)
4Options to purchase Class A common shares, par value $0.01
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+380,960
860,390 owned after
$13.29
exercise price
2009-01-22
2009-01-20Reichel W Carl
Officer (President, Pharmaceuticals)
4Options to purchase Class A common shares, par value $0.01
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+111,920
591,350 owned after
$13.29
exercise price
2009-01-22
2009-01-20Bruno Anthony D
Officer (Exec. V.P., Corp. Development)
4Options to purchase Class A common shares, par value $0.01
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+111,920
591,350 owned after
$13.29
exercise price
2009-01-22
2009-01-20Herendeen Paul
Officer (Exec. V.P. and CFO)
4Options to purchase Class A common shares, par value $0.01
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+111,920
591,350 owned after
$13.29
exercise price
2009-01-22